| ||Audit Committee||Compensation Committee||Nominating & Corporate Governance Committee|
|Cheryl R. Blanchard, Ph.D. |
|Cheryl R. Blanchard, Ph.D.|
Cheryl R. Blanchard, Ph.D. serves as a director of SeaSpine. Dr. Blanchard is a medical device and biologics executive with over 25 years of leadership experience. She is currently Chief Executive Officer of Microchips Biotech, Inc., a company developing implantable drug delivery products. Prior to that she was a corporate officer of Zimmer, Inc., a medical device company focused on musculoskeletal products, where she served as Senior Vice President, Chief Scientific Officer and general manager ...
|Keith Bradley, Ph.D. |
|Keith Bradley, Ph.D.|
Keith Bradley, Ph.D. serves as a director of SeaSpine. Since 1992, Dr. Bradley has been a director of Integra. In addition, Dr. Bradley currently serves as the chairman of the compensation committee of Integra’s board of directors and as a member of the nominating and corporate governance committee of Integra’s board of directors. Between 1996 and 2003, he was a director of Highway Insurance plc, an insurance company listed on the London Stock Exchange, and has been a consultant to a number of b...
|Stuart M. Essig, Ph.D. |
|Stuart M. Essig, Ph.D.|
Stuart M. Essig, Ph.D. serves as lead independent Director of SeaSpine. Dr. Essig currently serves as Managing Director of Prettybrook Partners LLC, which he cofounded in 2012. He is also currently Integra’s Chairman of the Board, where he has served as Chairman since January 2012 and as a director since he joined Integra in December 1997. He was Integra’s Chief Executive Officer from December 1997 until January 2012. Before joining Integra, Dr. Essig supervised the medical technology practice a...
| || ||
Michael Fekete serves as a director of SeaSpine. Mr. Fekete has served as an independent corporate advisor specializing in capital markets, mergers and acquisitions and general corporate strategy since 2009. From 2005 through 2009, Mr. Fekete was a Managing Director and Head of West Coast Healthcare Investment Banking for Wells Fargo / Wachovia Securities (acquired by Wells Fargo in December 2008). From 1986 to 2005, Mr. Fekete worked as an investment banker at CIBC World Markets, Oppenheimer & ...
|John B. Henneman, III |
|John B. Henneman, III|
John B. Henneman, III serves as a director of SeaSpine. Mr. Henneman has more than 22 years of combined financial and operational management experience in the life sciences industry. Since October 2014 Mr. Henneman has been the Executive Vice President and Chief Financial Officer of NewLink Genetics Corporation, a biotechnology company focused on cancer immunotherapy, where he is responsible for finance, law, quality and administration. Prior to joining NewLink Genetics, Mr. Henneman served Inte...
|| || |